Posts by Noëlle Aubert
Lonza | Hiring of 1200 people in Visp
Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been recruited. About Lonza One of the world’s leading suppliers to the pharmaceutical, healthcare and life science industries. Even today, the plant in Visp is still Lonza’s largest site and one of the most significant…
Read MoreCSEM | 2020 Digital Journey Award
Gait Up & Definition12 win the 2020 CSEM digital journey award CSEM has announced the two winners of its 2020 Digital Journey award: Gait Up based in the Canton of Vaud and Definition12, based in the Canton of Basel-Landschaft. These two healthcare SMEs will each receive CHF 100,000 in technological support from CSEM’s digital…
Read MoreSIB | Creation of a Swiss SARS-CoV-2 Data Hub
Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub Over the past weeks and with the threat of emerging variants growing, pressing calls for an open sharing of SARS-CoV-2 sequencing data were issued by the scientific community. Such sharing would allow fast, representative and large-scale research on the virus – but infrastructure and the…
Read MoreInait | Joined the Scale Up Vaud program
Artificial Brain Intelligence (ABI) An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud technology companies manage the scaling-up of their business in Switzerland as well as internationally. The general slowdown in investments generated by the global coronavirus pandemic since March 2020 has prompted Innovaud to adapt its support…
Read MoreNetsensing Technology | SmartEEs2 (EU H2020) contracting phase
The EU consortium will reinforce its penetration to global market & its position with EU partners Incubated at Microcity, Netsensing Technology Sàrl is excited to announce that after last year successful round of private investment and EU H2020 Digi-B-Cube grant, a new important step of the development of its automatic sleep apnea scoring cloud-based…
Read MoreTerapet | Proton therapy
CHF 1.5M of non-dilutive funding Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer, more precise, and time-saving proton therapy for cancer treatment, announced the combined successful awards of a total of about CHF 1’530’000 non-dilutive funds. The combined funding supports the development of Terapet’s first full-scale prototype to…
Read MoreAdiposs | Green light for clinical trials
ImageBAT Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK, the Geneva University spin-off Adiposs received endorsement for its flagship product, ImageBAT, to proceed to Clinical Trials. ImageBAT is the first product that makes brown and beige adipose tissue (BAT) visible with a fast and pain-free CT…
Read MoreCHUV, EPFL, HUG | AI now sees & hears COVID in your lungs
Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds DeepChest and DeepBreath, new deep learning algorithms developed at EPFL that identify patterns of COVID-19 in lung images and breath sounds, may help in the fight against other respiratory diseases and the growing challenge of antibiotic resistance.…
Read MoreBiopôle | Hosts the 1st branch of Superlab Suisse
The centre will open by the end of the 2nd quarter of 2021 Superlab Suisse AG, a Zurich-based private company offering the concept – unique in Switzerland – of the Lab as a Service to life sciences companies, is launching its first branch at Biopôle (Lausanne). The centre will host up to 15 companies…
Read MoreEBAMed | Swiss-based medtech startup
New CEO EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022. Former CEO and co-founder, Adriano Garonna has…
Read More